F.S. Abuzzahab

1.0k total citations
25 papers, 756 citations indexed

About

F.S. Abuzzahab is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, F.S. Abuzzahab has authored 25 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 6 papers in Clinical Psychology and 4 papers in Pharmacology. Recurrent topics in F.S. Abuzzahab's work include Schizophrenia research and treatment (8 papers), Electroconvulsive Therapy Studies (5 papers) and Treatment of Major Depression (4 papers). F.S. Abuzzahab is often cited by papers focused on Schizophrenia research and treatment (8 papers), Electroconvulsive Therapy Studies (5 papers) and Treatment of Major Depression (4 papers). F.S. Abuzzahab collaborates with scholars based in United States, Switzerland and Japan. F.S. Abuzzahab's co-authors include James L. Claghorn, Richard Wang, Richard M. Steinbook, Gilbert Honigfeld, V.B. Tuason, Gerald L. Klerman, Louis F. Fabre, J. Mendels, Joyce G. Small and Sanjay Dubé and has published in prestigious journals such as PLoS ONE, NeuroImage and Neurology.

In The Last Decade

F.S. Abuzzahab

25 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.S. Abuzzahab United States 11 395 162 140 105 95 25 756
H. Löo France 14 232 0.6× 164 1.0× 86 0.6× 145 1.4× 173 1.8× 51 838
Myung A. Lee United States 15 303 0.8× 171 1.1× 71 0.5× 93 0.9× 205 2.2× 22 801
Ching‐Jui Chang Taiwan 16 426 1.1× 157 1.0× 71 0.5× 44 0.4× 56 0.6× 26 877
Arnold E. Merriam United States 15 732 1.9× 155 1.0× 80 0.6× 73 0.7× 121 1.3× 28 1.4k
Martin Kärner Italy 13 259 0.7× 258 1.6× 45 0.3× 108 1.0× 77 0.8× 22 799
Jinguo Zhai China 19 415 1.1× 121 0.7× 63 0.5× 160 1.5× 84 0.9× 55 971
Dominique Januel France 12 245 0.6× 123 0.8× 111 0.8× 80 0.8× 48 0.5× 37 696
Maurizio De Vanna Italy 10 101 0.3× 152 0.9× 63 0.5× 61 0.6× 136 1.4× 24 496
Baer Arts Netherlands 16 1.2k 3.0× 204 1.3× 126 0.9× 127 1.2× 58 0.6× 24 1.6k
David Rosenberg United States 14 319 0.8× 348 2.1× 59 0.4× 56 0.5× 138 1.5× 23 998

Countries citing papers authored by F.S. Abuzzahab

Since Specialization
Citations

This map shows the geographic impact of F.S. Abuzzahab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.S. Abuzzahab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.S. Abuzzahab more than expected).

Fields of papers citing papers by F.S. Abuzzahab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.S. Abuzzahab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.S. Abuzzahab. The network helps show where F.S. Abuzzahab may publish in the future.

Co-authorship network of co-authors of F.S. Abuzzahab

This figure shows the co-authorship network connecting the top 25 collaborators of F.S. Abuzzahab. A scholar is included among the top collaborators of F.S. Abuzzahab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.S. Abuzzahab. F.S. Abuzzahab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pardo, José V., Sohail A. Sheikh, Graeme Schwindt, et al.. (2020). A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination. PLoS ONE. 15(1). e0226486–e0226486. 6 indexed citations
2.
Pardo, José V., Sohail A. Sheikh, Graeme Schwindt, et al.. (2008). Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism. NeuroImage. 42(2). 879–889. 54 indexed citations
3.
Flick, Lisa M., Jason M. Weaver, Michael Ulrich‐Vinther, et al.. (2003). Effects of receptor activator of NFκB (RANK) signaling blockade on fracture healing. Journal of Orthopaedic Research®. 21(4). 676–684. 73 indexed citations
4.
Sheikh, Sohail A., F.S. Abuzzahab, Jong‐Wook Lee, José V. Pardo, & Matthew Hagen. (2002). Metabolic abnormalities of severe, chronic treatment resistant depression post VNS implant. European Psychiatry. 17. 112–112. 1 indexed citations
5.
Pryor, Jon L., et al.. (1997). Premature Ejaculation: A psychophysiological review. Journal of Sex & Marital Therapy. 23(1). 3–23. 79 indexed citations
6.
Fabre, Louis F., F.S. Abuzzahab, Mohamed Amin, et al.. (1995). Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo. Biological Psychiatry. 38(9). 592–602. 147 indexed citations
7.
Abuzzahab, F.S.. (1990). Long term effects of clozapine in outpatient schizophrenia. European Journal of Pharmacology. 183(5). 1896–1896. 1 indexed citations
8.
Claghorn, James L., Gilbert Honigfeld, F.S. Abuzzahab, et al.. (1987). The Risks and Benefits of Clozapine versus Chlorpromazine. Journal of Clinical Psychopharmacology. 7(6). 377???384–377???384. 235 indexed citations
9.
Abuzzahab, F.S., et al.. (1979). Informed Consent: Legal Requirements in Psychiatric Practice. The Journal of Psychiatry & Law. 7(4). 479–491. 1 indexed citations
10.
Abuzzahab, F.S., et al.. (1979). Anxious Symptomatic Volunteers in the Twin Cities: Sociodemographic Description and MMPI Psychodiagnosis. The Journal of Clinical Pharmacology. 19(8-9). 467–475. 4 indexed citations
11.
Eldridge, Roswell, et al.. (1978). Gilles de la Tourette syndrome. Neurology. 28(3). 304–304. 45 indexed citations
12.
Abuzzahab, F.S., et al.. (1978). Long-term effects of lithium carbonate on serum protein bound iodine in affective disorders. Progress in Neuro-Psychopharmacology. 2(3). 369–377. 4 indexed citations
13.
Abuzzahab, F.S., et al.. (1977). A Double Blind Investigation of Piracetam (Nootropil) vs Placebo in Geriatric Memory. Pharmacopsychiatry. 10(2). 49–56. 21 indexed citations
14.
Abuzzahab, F.S., et al.. (1975). A Three Year Double Blind Investigation of the Effects of Lithium Carbonate on Serum Protein-Bound Iodine in Manic Depressive Patients. Neuropsychobiology. 1(5). 304–312. 4 indexed citations
15.
Abuzzahab, F.S., et al.. (1974). Gilles de la Tourette's syndrome: Cross-cultural analysis and treatment outcome. Clinical Neurology and Neurosurgery. 77(1). 66–74. 15 indexed citations
16.
Kelly, John, Robert Zimmermann, F.S. Abuzzahab, & Burtrum C. Schiele. (1974). A Double-Blind Study of Amantadine Hydrochloride versus Benztropine Mesylate in Drug-Induced Parkinsonism. Pharmacology. 12(2). 65–73. 18 indexed citations
17.
Abuzzahab, F.S.. (1973). Long‐Term Use of Molindone in Schizophrenics. PubMed. 13(10). 422–426. 1 indexed citations
18.
Abuzzahab, F.S.. (1970). Some Uses of Haloperidol in the Treatment of Psychiatric Conditions. Psychosomatics. 11(3). 188–193. 3 indexed citations
19.
Abuzzahab, F.S.. (1970). Clinical Psychopharmacology. Postgraduate Medicine. 48(4). 189–195. 10 indexed citations
20.
Abuzzahab, F.S.. (1969). Psychopharmacologic Agents in the Prevention of Psychiatric Disorders. Postgraduate Medicine. 46(4). 141–144. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Löo Breakdown of academic impact, for papers by Myung A. Lee Breakdown of academic impact, for papers by Ching‐Jui Chang Breakdown of academic impact, for papers by Arnold E. Merriam Breakdown of academic impact, for papers by Martin Kärner Breakdown of academic impact, for papers by Jinguo Zhai Breakdown of academic impact, for papers by Dominique Januel Breakdown of academic impact, for papers by Maurizio De Vanna Breakdown of academic impact, for papers by Baer Arts Breakdown of academic impact, for papers by David Rosenberg
Rankless by CCL
2026